Dysphoria after treatment with ondansetron.
Oren
D A
DA
D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects; D003866:Depressive Disorder / Q000139:chemically induced*; D005260:Female; D006801:Humans; D009325:Nausea / Q000139:chemically induced / Q000188:drug therapy; D017294:Ondansetron / Q000009:adverse effects*
D000970:Antineoplastic Agents; D017294:Ondansetron